Lyly Le - Concepedia

Author

Lyly Le

Princess Margaret Cancer Centre

Also Known As

B. Fautrel, L Le, L. H. Le, L. Le, L.H. Le, L.H. Lê, LINH HUU LÊ, Lam Ngo Le, Lyly H. Le, Lyly H. Lê

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Princess Margaret Cancer Centre BC Cancer Agency Human Genome Sciences (United States)Hamilton Regional Laboratory Medicine Program Ontario Institute for Cancer Research

About

Lyly Le is an author at Princess Margaret Cancer Centre specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	556
2	Pharmacology	4	4	434
3	Immunology	3	3	54
4	Pathology	3	3	101
5	Autoimmune Disease	2	2	35

Lyly Le

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial Daniel Khalaf, Matti Annala, Sinja Taavitsainen, The Lancet Oncology UrologyOncologyOptimal SequencingCrossover TrialGenitourinary Cancer	2019	338
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas Ignacio Durán, Jeremy Kortmansky, Deepti Singh, British Journal of Cancer	2006	316
A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies Sébastien J. Hotte, Hal W. Hirte, Eric X. Chen, Clinical Cancer Research	2008	189
Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone Lesions Lyly Le, Kim Chi, Scott Tyldesley, Clinical Chemistry	2005	120
Epidermal Growth Factor Receptor Expression in Anal Canal Carcinoma Lyly Le, Runjan Chetty, Malcolm J. Moore American Journal of Clinical Pathology Tumoral PathologyMedicineTumor GrowthCancer GrowthPathology	2005	66
Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days Lyly Le, Charles Erlichman, L. Pillon, Investigational New Drugs MedicinePharmacokinetic StudyFive Consecutive DaysIntravenous Bolus DailyPharmacology	2004	39
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours Lyly Le, Malcolm J. Moore, Lillian L. Siu, Cancer Chemotherapy and Pharmacology OncologyMedicineAdvanced Solid TumoursPharmacotherapyAnti-cancer Agent	2005	38
A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209 Bernhard J. Eigl, Kim Chi, Dongsheng Tu, Oncotarget	2018	30
Phase I study of a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 4 (TRAIL-R1) in subjects with advanced solid malignancies or non-Hodgkin's lymphoma (NHL) Lyly Le, Holger W. Hirte, Sébastien J. Hotte, Journal of Clinical Oncology ApoptosisImmunologyImmunoeditingCell DeathPathology	2004	25
A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer Jorg Michels, Susan Ellard, Lyly Le, Annals of Oncology Phase Ib StudyUrologyGenitourinary CancerMedicineCancer Treatment	2009	21

Page 1